Skip to search formSkip to main contentSkip to account menu

PF-477736

Known as: PF-00477736, PF477736 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The invariable development of drug resistance represents a major obstacle to the successful treatment of cancer with kinase… 
2017
2017
Reduction in nucleotide pools through the inhibition of mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) has been… 
2014
2014
Background: Chk1 inhibitors are currently in clinical trials as putative potentiators of cytotoxic chemotherapy drugs. Chk1… 
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Checkpoint kinase1 (CHK1) is a DNA damage kinase, which… 
2014
2014
Mantle Cell Lymphoma (MCL) is an aggressive lymphoma, for which there is not yet a standard therapy. Deregulation of cell cycle… 
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Malignant pleural mesothelioma (MPM) is a highly… 
Highly Cited
2009
Highly Cited
2009
Purpose: Checkpoint kinase 1 (Chk1) plays a critical role in the activation of mitotic spindle checkpoint and DNA damage… 
2007
2007
5386 CHK1 kinase is a key regulator of the S and G2 cell cycle checkpoints that are activated in response to DNA damage. Cell…